Genelux (GNLX) Other financing activities (2022 - 2026)
Genelux (GNLX) recorded quarterly Other financing activities of $1.4 million in Q1 2026, down 4.26% quarter-over-quarter from $1.5 million in Q4 2025, and down 2.04% on a YoY basis from $1.4 million in Q1 2025.
Genelux (GNLX) Other financing activities (2022 - 2026) Analysis & Trends
Genelux's Other financing activities history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2026.
- In Q1 2026, Other financing activities fell 2.04% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $5.8 million (up 1.6% YoY), while the FY2025 annual figure was $5.8 million, up 0.94% from the prior year.
- Other financing activities was $1.4 million for Q1 2026 at Genelux, down from $1.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.6 million in Q3 2025 to a low of $303000.0 in Q1 2023.
- Historically, Other financing activities has averaged $1.2 million across 5 years, with a median of $1.4 million in 2025.
- The sharpest annual moves came in 2024 and 2025: Other financing activities jumped 391.42% in 2024, then dropped 4.43% in 2025.
- A 5-year view of Other financing activities shows it stood at $555000.0 in 2022, then sank by 45.41% to $303000.0 in 2023, then jumped by 371.95% to $1.4 million in 2024, then rose by 1.82% to $1.5 million in 2025, then slipped by 4.26% to $1.4 million in 2026.
- The last three Other financing activities figures came in at $1.4 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Genelux | 129.36 Mn | 129.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.39 Mn |
| Mar 31, 2026 | 1.39 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Jun 30, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Mar 31, 2025 | 1.42 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Dec 31, 2024 | 1.43 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Sep 30, 2024 | 1.52 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2024 | 1.49 Mn |
| Mar 31, 2023 | 303,000.00 |
| Mar 31, 2023 | 303,000.00 |